Literature DB >> 20127686

Protein subcellular localization profiling of breast cancer cells by dissociable antibody microarray staining.

Guanyuan Fu1, X Cynthia Song, Xufen Yang, Tao Peng, Yingjian Wang, G Wayne Zhou.   

Abstract

We have developed dissociable antibody microarray (DAMA) staining technology that provides a new approach to the global analysis of protein subcellular localization (SCL) in fixed cells. We have developed and optimized this technology for protein SCL profiling, generated ChipView, a program for management and analysis of molecular image database, and utilized the technique to identify proteins with unique SCL in breast cancer cell lines. We compared the SCL profiles of 325 proteins among nine different breast cell lines, and have identified one protein, Cyclin B1, with distinctively different SCLs between normal and cancer cell lines. With classic individual immunostaining, Cyclin B1 was confirmed to localize to the cytoplasm of seven breast cancer cell lines and in both cytoplasm and nuclei of two normal breast cell lines, and to have higher expression levels in the cancer cell lines tested.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127686      PMCID: PMC3077420          DOI: 10.1002/pmic.200900585

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  42 in total

1.  Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins.

Authors:  A Sreekumar; M K Nyati; S Varambally; T R Barrette; D Ghosh; T S Lawrence; A M Chinnaiyan
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

Review 2.  Approaches for systematic proteome exploration.

Authors:  Ronny Falk; Margareta Ramström; Stefan Ståhl; Sophia Hober
Journal:  Biomol Eng       Date:  2007-02-06

3.  Antigen microarrays for serodiagnosis of infectious diseases.

Authors:  Letizia Mezzasoma; Tito Bacarese-Hamilton; Manlio Di Cristina; Ruggero Rossi; Francesco Bistoni; Andrea Crisanti
Journal:  Clin Chem       Date:  2002-01       Impact factor: 8.327

4.  Global analysis of protein activities using proteome chips.

Authors:  H Zhu; M Bilgin; R Bangham; D Hall; A Casamayor; P Bertone; N Lan; R Jansen; S Bidlingmaier; T Houfek; T Mitchell; P Miller; R A Dean; M Gerstein; M Snyder
Journal:  Science       Date:  2001-07-26       Impact factor: 47.728

5.  Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis.

Authors:  Z E Winters; N C Hunt; M J Bradburn; J A Royds; H Turley; A L Harris; C J Norbury
Journal:  Eur J Cancer       Date:  2001-12       Impact factor: 9.162

6.  Proteomic profiling of the cancer microenvironment by antibody arrays.

Authors:  V Knezevic; C Leethanakul; V E Bichsel; J M Worth; V V Prabhu; J S Gutkind; L A Liotta; P J Munson; E F Petricoin; D B Krizman
Journal:  Proteomics       Date:  2001-10       Impact factor: 3.984

7.  Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor.

Authors:  Takashi Suzuki; Tomohiro Urano; Yasuhiro Miki; Takuya Moriya; Jun-ichi Akahira; Takanori Ishida; Kuniko Horie; Satoshi Inoue; Hironobu Sasano
Journal:  Cancer Sci       Date:  2007-03-14       Impact factor: 6.716

Review 8.  A genecentric Human Protein Atlas for expression profiles based on antibodies.

Authors:  Lisa Berglund; Erik Björling; Per Oksvold; Linn Fagerberg; Anna Asplund; Cristina Al-Khalili Szigyarto; Anja Persson; Jenny Ottosson; Henrik Wernérus; Peter Nilsson; Emma Lundberg; Asa Sivertsson; Sanjay Navani; Kenneth Wester; Caroline Kampf; Sophia Hober; Fredrik Pontén; Mathias Uhlén
Journal:  Mol Cell Proteomics       Date:  2008-10       Impact factor: 5.911

9.  Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol.

Authors:  Ilija Androic; Andrea Krämer; Ruilan Yan; Franz Rödel; Regine Gätje; Manfred Kaufmann; Klaus Strebhardt; Juping Yuan
Journal:  BMC Cancer       Date:  2008-12-29       Impact factor: 4.430

10.  LOCATE: a mammalian protein subcellular localization database.

Authors:  Josefine Sprenger; J Lynn Fink; Seetha Karunaratne; Kelly Hanson; Nicholas A Hamilton; Rohan D Teasdale
Journal:  Nucleic Acids Res       Date:  2007-11-05       Impact factor: 16.971

View more
  3 in total

Review 1.  Bioanalysis of eukaryotic organelles.

Authors:  Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga
Journal:  Chem Rev       Date:  2013-04-10       Impact factor: 60.622

2.  KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.

Authors:  A T Alshareeda; O H Negm; A R Green; C C Nolan; P Tighe; N Albarakati; R Sultana; S Madhusudan; I O Ellis; E A Rakha
Journal:  Br J Cancer       Date:  2015-05-19       Impact factor: 7.640

3.  Reinventing diagnostics for personalized therapy in oncology.

Authors:  Diponkar Banerjee
Journal:  Cancers (Basel)       Date:  2010-06-02       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.